<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hara</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Kikuchi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Miyashita</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hatsuta</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Saito</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kasuga</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2017</year>). 
  <article-title>Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimerâ€™s disease.</article-title>
  <source>
   <italic>Acta Neuropathol. Commun.</italic>
  </source>
  <volume>5</volume>:
  <issue>10</issue>. 
  <pub-id pub-id-type="doi">10.1186/s40478-017-0414-z</pub-id>
  <?supplied-pmid 28137310?>
  <pub-id pub-id-type="pmid">28137310</pub-id>
 </mixed-citation>
</ref>
